What is DIPG?

DIPG (diffuse intrinsic pontine glioma) is a disease which strikes at the heart of childhood and it is a disease in desperate need of a cure.
And at the same time, there may be no better place to start the search.
Lung cancer has a survival rate of 80% if caught in the early stages to less than 5% if caught in stage 5.
Breast cancer has typically an 80-90% survival rate.
Leukemia has a 48% survival rate. At the same time less than 10% of DIPG children will live longer than 18 months from diagnosis.
Survival is even more rare.


DIPG affects the pons portion of the brainstem, rendering nervous system function impossible.
Symptoms include double vision, inability to close the eyelids completely, dropping one side of the face, and difficulty chewing and swallowing.
Unfortunately these symptoms usually worsen rapidly because the tumor is rapidly growing.

DIPG, for all its difficulties, presents an opportunity for all forms of cancer.
It is one of the most resistant of all cancers to chemotherapy treatments, it affects
primarily children that have historically led innovations in many other forms of cancer,
and with a "dismal" prognosis, alternatives are few.
Put together, these obstacles offer researchers a chance to revolutionize cancer research and prevention.
It is even suggested that a cure to DIPG might result in a cure for almost every other type of cancer.
For this reason, the cure starts now.

Taken from The Cure Starts Now

HTML Hit Counters